Haemophilic arthropathy of the ankle treated by total ankle replacement: a case series

Summary. The standard treatment for end‐stage osteoarthritis of the ankle joint in haemophilic patients has been fusion of the ankle joint. Total ankle replacement is still controversial as a treatment option. The objective of this prospective study was to evaluate the mid‐term outcome in patients treated with total ankle replacement using an unconstrained three‐component ankle implant. Ten haemophilic ankles in eight patients (mean age: 43.2 years, range 26.7–57.5) treated with total ankle replacement were followed up for a minimum of 2.7 years (mean: 5.6, range 2.7–7.6). The outcome was measured with clinical and radiological evaluations. There were no intra‐ or peri‐operative complications. The AOFAS‐hindfoot‐score increased from 38 (range 8–57) preoperatively to 81 (range 69–95) postoperatively. All patients were satisfied with the results. Four patients became pain free; in the whole patient cohort pain level decreased from 7.1 (range 4–9) preoperatively to 0.8 (range 0–3) postoperatively. All categories of SF‐36 score showed significant improvements in quality of life. In one patient, open ankle arthrolysis was performed because of painful arthrofibrosis. For patients with haemophilic osteoarthritis of the ankle joint, total ankle replacement is a valuable alternative treatment to ankle fusion.